EMD-37290

Single-particle
3.3 Å
EMD-37290 Deposition: 26/08/2023
Map released: 26/02/2025
Last modified: 26/02/2025
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-37290

Cryo-EM structure of Qb-Ab6

EMD-37290

Single-particle
3.3 Å
EMD-37290 Deposition: 26/08/2023
Map released: 26/02/2025
Last modified: 26/02/2025
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Mus musculus, Mus, Escherichia phage Qbeta
Sample: Complex of Qb-Ab6
Fitted models: 8w5f (Avg. Q-score: 0.53)

Deposition Authors: Bao KY, Li RH, Hua ZL, Hou BD, Zhu P
Competition propels, rather than limits, the success of low-affinity B cells in the germinal center response.
Li R, Bao K, Liu C, Ma X, Hua Z, Zhu P, Hou B
(2025) Cell Rep , 44 , 115334 - 115334
PUBMED: 39955776
DOI: doi:10.1016/j.celrep.2025.115334
ISSN: 2211-1247
Abstract:
The germinal center (GC) sets an environment where antigen-specific B cells are compelled to continuously increase their affinity to compete for the antigen and obtain Tfh help for survival and propagation. Previous studies indicated that low-affinity B cells are disadvantaged in the presence of high-affinity ones, suggesting that competition may lead to the elimination of low-affinity B cells and their descendants. However, using a multivalent virus-mimicking antigen, our study demonstrates that low-affinity B cells not only successfully participate in GC responses alongside high-affinity B cells but also undergo accelerated affinity maturation under the more stringent competition. Furthermore, our cryo-electron-microscopy-based structural analysis reveals that both low-affinity and high-affinity B cells compete for the same antigenic epitope. Although the applicability of this idealized GC competition to true pathogen-induced responses remains uncertain, this change in perspective on the role of competition in low-affinity B cell evolution provides valuable insights for vaccine development.